MAIDEN HOLDINGS LTD (MHLD)

BMG5753U1128 - Common Stock

2.25  +0.04 (+1.81%)

After market: 2.25 0 (0%)

Fundamental Rating

0

MHLD gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 141 industry peers in the Insurance industry. Both the profitability and financial health of MHLD have multiple concerns. MHLD does not seem to be growing, but still is valued expensively.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MHLD has reported negative net income.
In the past year MHLD has reported a negative cash flow from operations.
In multiple years MHLD reported negative net income over the last 5 years.
In the past 5 years MHLD always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.54%, MHLD is doing worse than 86.43% of the companies in the same industry.
With a Return On Equity value of -15.48%, MHLD is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.54%
ROE -15.48%
ROIC N/A
ROA(3y)1.82%
ROA(5y)0.89%
ROE(3y)11.41%
ROE(5y)4.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MHLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

MHLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
MHLD has less shares outstanding than it did 1 year ago.
MHLD has more shares outstanding than it did 5 years ago.
MHLD has a worse debt/assets ratio than last year.

2.2 Solvency

A Debt/Equity ratio of 1.02 is on the high side and indicates that MHLD has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.02, MHLD is doing worse than 87.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.71%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

1

3. Growth

3.1 Past

MHLD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -158.79%.
The Revenue has grown by 13.62% in the past year. This is quite good.
MHLD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -47.89% yearly.
EPS 1Y (TTM)-158.79%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-150.15%
Revenue 1Y (TTM)13.62%
Revenue growth 3Y-23.55%
Revenue growth 5Y-47.89%
Revenue growth Q2Q50.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MHLD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MHLD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAIDEN HOLDINGS LTD

NASDAQ:MHLD (5/3/2024, 7:05:52 PM)

After market: 2.25 0 (0%)

2.25

+0.04 (+1.81%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap322.54M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.54%
ROE -15.48%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-158.79%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.62%
Revenue growth 3Y-23.55%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y